SPONSORS & EXHIBITORS
CEPI Global South
Sentosa is Asia’s leading leisure destination, Singapore’s premier island resort getaway, and the perfect island-in-the-city with exciting possibilities for any business occasion. Located just 15 minutes from the city centre, with a unique range of experiences and world-class venues in one place, there is always something to discover in Sentosa.
Read more https://www.sentosa.com.sg/
The Australian Government's Indo-Pacific Centre for Health Security is at the forefront of Australia’s effort to advance the One Health approach internationally with a specific focus on the Indo Pacific region. Established in 2017 and housed within the Department of Foreign Affairs and Trade, the Centre contributes to the avoidance and containment of infectious disease threats with the potential to cause social and economic harms on a national, regional or global scale. The Centre manages Australia’s investments in country and regional projects in the Pacific and Southeast Asia support the strengthening of health information systems; disease surveillance and modelling; infection prevention and control, including antimicrobial resistance (AMR); vector surveillance and control; emergency operations; laboratory capacity; and workforces. These project investments are complemented by targeted support for the work of key multilateral organisations in our region, including the World Health Organization. The Centre supports the Ambassador for Regional Health Security, is advised by a Technical Reference Group, and draws on expertise from across government, academic, research and other organisations. Visit https://indopacifichealthsecurity.dfat.gov.au/to learn more about what Australia is doing with our partners in the region.
As the world’s leading animal health company, we are driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After nearly 70 years innovating ways to predict, prevent, detect, and treat animal illness, we continue to stand by those raising and caring for animals worldwide - from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies make a difference in over 100 countries. In 2020, we generated revenue of $6.7 billion with ~11,300 employees.
For more, visit url: http://www.zoetis.com/
CABI is an academic publisher whose One Health resources include an open access journal, a collection of educational case studies, and a searchable database of One Health content.
visit url: https://cabidigitallibrary.org/journal/cabioh
Oxford Nanopore Technologies plc
Oxford Nanopore Technologies has developed the world's first and only nanopore DNA/RNA sequencing devices, scalable to your requirements. Oxford Nanopore brings real-time sequencing with unrestricted read lengths, to anyone, anywhere, whether in scientific research, education, or real-world applications.
visit url: https://nanoporetech.com/
Borries Pte Ltd
Borries Pte Ltd is an innovative Singapore technology company that develops and manufactures the world most advanced Rapid Automated Virus Imaging and Surveillance System in Screening and Diagnostic to help defend against future outbreaks/pandemics
visit url: https://borriestech.com/
Temasek Foundation supports programmes that uplift lives and communities in Singapore and beyond. We aim to strengthen social resilience, foster international exchange and enhance regional capabilities, advance science and protect the planet for a sustainable world. Temasek Foundation’s programmes, made possible through philanthropic endowments gifted by Temasek, strive towards achieving positive outcomes for individuals and communities now, and for generations to come. For more information,
visit url: www.temasekfoundation.org.sg
Illumina is a global genomics and human health company powering the future of personalized medicine. Our industry leading research and innovation is enabling clinicians to detect and diagnose diseases earlier, opening new and more effective treatment options for patients. Driven by our mission to improve human health by unlocking the power of the genome, we are committed to making our technology affordable and accessible, realizing health equity for billions around the world.
At Illumina, we push boundaries. We think beyond the conventional. We dream big. We strive to make our solutions increasingly simple, more accessible, and always reliable. What is the origin of a puzzling disease? Is it possible to prevent the next pandemic? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us.
We aim to build a global community of innovators, partners, investors and educators passionate about genomics. Because together, we can drive forward the adoption of genomics and transform human health.
The National Institute of Parasitic Diseases (NIPD) of the Chinese Centre for Diseases Control and Prevention is a leader in the fight against parasitic diseases in China, with an influential track record of publishing cutting-edge science about parasite biology, epidemiology, and immunology for more than 70 years. The institute is WHO collaborating center for tropical diseases and MoH key laboratory on parasite and vector biology since 1980s.
CEPI is an innovative global partnership between public, private, philanthropic, and civil society organisations working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need.
Gordon and Betty Moore Foundation
Gordon and Betty Moore established the foundation to create positive outcomes for future generations. In pursuit of that vision, we foster path-breaking scientific discovery, environmental conservation, patient care improvements and preservation of the special character of the San Francisco Bay Area
Thermo Fisher Scientific is the world leader in serving science, with over 100,000 employees spread around the globe that are working toward our mission of enabling our customers to make the world healthier, cleaner and safer. In 2020, our ability to cost-effectively meet urgent COVID-19 testing needs catapulted us into the world of global health, where we became the largest supplier of SARS-CoV-2 qPCR testing to lower and middle-income countries, via UNICEF and WHO. We are committed to expanding our partnership with the global health community through development and deployment of holistic, cost-effective solutions across the diagnostic continuum that address endemic infectious diseases along with emerging diseases of public health concern.
Botnar Research Centre for Child Health (BRCCH)
The Botnar Research Centre for Child Health (BRCCH) was jointly founded by the University of Basel and ETH Zurich in 2018. The Centre addresses unmet pediatric medical needs, focusing on the development of new healthcare solutions for the benefit of young people worldwide.
Accord Healthcare is a fast-growing global pharmaceutical company that develops, manufactures and distributes generics medicines and biosimilars in over 85 countries worldwide. Accord's therapeutic portfolio includes Oncology, Cardiology, Neurology, Psychiatry, Diabetes, and many others.
Hilleman Laboratories is an equal joint venture between MSD and Wellcome Trust, with a mission to develop affordable vaccines and biologics against infectious diseases for populations in low- and middle-income countries. Hilleman Laboratories collaborates with local, regional, and global partners and stakeholders to facilitate access to life-saving vaccines.
Chan Zuckerberg Initiative
The Chan Zuckerberg Initiative was founded in 2015 to help solve some of society’s toughest challenges — from eradicating disease and improving education, to addressing the needs of our local communities. Through collaboration, providing resources, and building technology, our mission is to help build a more inclusive, just, and healthy future for everyone. For more information, please visit
The UK Department for International Trade is the economic development arm of the British government. We secure UK and global prosperity by promoting and financing international trade and investment. We work with international partners to improve healthcare in the UK and around the world. Reach out if you'd like to learn about the latest UK One Health innovations or opportunities
MGI Tech Co., Ltd. (MGI), an affiliate of BGI Group, is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production and sales of sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI's mission is to develop and promote advanced life science tools for future healthcare.
Canada’s Weapons Threat Reduction Program
The Weapons Threat Reduction Program (WTRP), Canada’s contribution to the G7-led Global Partnership Against the Spread of Weapons and Materials of Mass Destruction is a leader in building global capacity to prevent, detect and respond to infectious disease threats. The WTRP is assisting dozens of countries and international/regional organisations to strengthen biosafety and biosecurity for pathogens of security concern, enhance surveillance and diagnostic capabilities and improve capacities to mitigate biological threats. WTRP programming is guided by the GP’s Biosecurity Deliverables, which were developed under Canada’s 2010 G7 presidency and renewed during Canada’s 2018 presidency. These provide the parameters for coordinated action by GP members to:
- secure and account for dangerous pathogens;
- prevent deliberate misuse of pathogens;
- enhance regional surveillance networks;
- reinforce biological non-proliferation instruments; and
- promote responsible conduct in biological sciences.
Canada’s WTRP is a leading contributor to the GP’s Signature Initiative to Mitigate Biological Threats in Africa and is committed to identifying new partnerships and innovations to strengthen global health security.
Canada’s Weapons Threat Reduction Program
GenScript Biotech Corporation
GenScript Biotech Corp (Stock Code: 1548.HK) is the world’s leading life science technology and service provider. GenScript Biotech's operations span over 100 countries worldwide with legal entities located in the US, Mainland China, Hong Kong, China, Japan, Singapore, the Netherlands and Ireland. GenScript Biotech is divided into four major platforms: life science service and product platform, biologics contract development and manufacturing organization (CDMO) platform, cell therapy platform and industrial biological product synthesis platform.
For more information, please visit GenScript Biotech's official website https://www.genscript.com.